Abstract
Reduced clearance of insulin from plasma contributes to the hyperinsulinemia associated with essential hypertension (EH); however, the association between impaired insulin clearance and EH remains unexplained. Whether elevated blood pressure (BP) affects insulin clearance is unknown; therefore, we used the hyperinsulinemic euglycemic clamp to determine the effects of BP elevation on insulin clearance and sensitivity in eight healthy volunteers. Placebo infusion increased mean BP by 2.6+/-1.6 mm Hg, which was significantly less than rises produced by phenylephrine, an alpha1-adrenoceptor agonist (+11+/-1.8 mmHg, P<.05), or by angiotensin II (+13+/-1.3 mmHg, P<.01). Although beta-adrenoceptor stimulation with isoproterenol did not change mean BP (+3.6 mm Hg, P=NS), it significantly increased systolic pressure (+23+/-2.8 mm Hg versus +2.3+/-4.6 mm Hg with placebo P<.01). Insulin secretion (ie, C-peptide concentrations) was not affected by any of the treatments; however, phenylephrine significantly reduced the metabolic clearance rate of insulin (MCRinsulin) (16.6+/-1.0 mL/kg per minute with placebo versus 13.6+/-0.7 mL/kg per minute with phenylephrine, P<.01) and thereby increased plasma insulin concentrations (66+/-5.1 microU/mL ...Continue Reading
References
Mar 1, 1979·Diabetes Care·T A Welborn, K Wearne
Jun 1, 1992·American Journal of Hypertension·D GiuglianoF D'Onofrio
Jan 1, 1991·Life Sciences·G DesoyeS Porta
Jun 1, 1990·Diabetes Care·H RasmussenW S Zawalich
Sep 18, 1987·Science·O M Rosen
Jul 1, 1989·Journal of Hypertension·T PollareS Ljunghall
Sep 28, 1989·The New England Journal of Medicine·T PollareC Berne
Oct 1, 1989·Hypertension·A P RocchiniM Gregory
May 1, 1986·The Journal of Clinical Endocrinology and Metabolism·Y KawaiI J Arinze
Jul 1, 1986·Diabetologia·I LagerU Smith
Oct 1, 1988·Diabetes·H TillilK S Polonsky
Dec 1, 1988·Diabetes·G M Reaven
Jul 1, 1988·Diabetologia·T PollareC Berne
Aug 6, 1987·The New England Journal of Medicine·E FerranniniS Bevilacqua
Mar 1, 1985·Diabetes·R I FinkJ M Olefsky
Nov 1, 1967·The Journal of Clinical Investigation·G M ReavenJ W Farquhar
Mar 1, 1980·The Journal of Clinical Investigation·D C Deibert, R A DeFronzo
Mar 1, 1984·The Journal of Clinical Endocrinology and Metabolism·R P EatonD S Schade
May 1, 1984·Diabetes·K S Polonsky, A H Rubenstein
Mar 1, 1980·Diabetes·V Leclercq-MeyerW J Malaisse
May 1, 1981·Hypertension·A MeierW H Ziegler
Oct 1, 1981·Diabetes·L DoberneG M Reaven
Sep 1, 1994·Clinical and Experimental Hypertension : CHE·W H SheuM M Fuh
Jul 1, 1994·Diabetes/metabolism Reviews·M J CastilloP J Lefèbvre
Aug 1, 1993·The Journal of Clinical Investigation·T A BuchananW Hsueh
Sep 1, 1993·Diabetologia·P O Ganrot
Feb 8, 1996·The New England Journal of Medicine·G M ReavenL Landsberg
Jan 1, 1997·Hypertension·D LenderP Raskin
Citations
Feb 2, 2013·Diabetologia·A NataliE Ferrannini
Mar 29, 2005·Vascular Pharmacology·Nana GletsuKenneth E Bernstein
Apr 9, 1999·Alcoholism, Clinical and Experimental Research·M PassiltaY A Kesäniemi
Nov 4, 2000·Expert Opinion on Investigational Drugs·R Komers, K Komersova
Dec 12, 2012·Diabetes, Obesity & Metabolism·C C LeeA J Hanley
Aug 25, 2015·Cardiovascular Diabetology·Nora E StraznickyGavin W Lambert
May 13, 1999·Blood Pressure·C J O'CallaghanW J Louis